Industri

Josh de Los Santos – Employee Spotlight

Meet Josh de Los Santos – Senior Manager, Drug Product Manufacturing at Argonaut...

Beyond the ladder: Why sustainable growth needs to be T...

If one looks at the organisations that have excelled in their core operating ar...

Pharma trends that will shape 2026: Building a future-r...

As we move closer to 2026, the pharmaceutical ecosystem is undergoing a profoun...

Breaking Moscow’s Energy Grip on Bulgaria: The Lukoil C...

Bulgaria’s refining sector has revolved around a single asset for nearly three d...

What Stonepeak buying Castrol’s 65% really means for co...

At its core, this deal isn’t complicated. It’s about capital, focus, and executi...

BD invests $110m to expand US prefillable syringe produ...

The company aims to strengthen the pharmaceutical supply chain and accelerate th...

Fortress Biotech receives FDA approval for Zycubo to tr...

Menkes disease is a rare X-linked recessive disorder caused by mutations in the ...

Inside the world of pharma consulting: The career that ...

When a survey by TCS and the Association of Management Consulting Firms reveale...

Our goal is to help companies reduce cost per cubic met...

The pharma industry is considered one of the most polluting industries, not jus...

Beyond the Warehouse Doors: How MVS Pharma Ensures GDP-...

Transportation is a critical extension of pharmaceutical distribution activities...

Amneal unveils new brand to reimagine what’s possible i...

Amneal Pharmaceuticals introduced a bold new brand and visual identity that ref...

Next big leap in Indian pharma’s digital journey, AI-le...

Archimedis Digital, a leading digital transformation partner for life sciences ...

India’s Pharma 2047: How academia can drive innovation ...

As India marches toward its 2047 vision of becoming an innovation-led, self-rel...

Omega-3 Longevity and Lifespan Benefits: Insights from ...

Omega-3 Longevity and Lifespan Benefits Overview: A growing body of evidence fro...

Atara receives FDA complete response letter for Ebvallo...

The application sought approval for Ebvallo as monotherapy in adult and paediatr...

SciNeuro and Novartis sign global licensing deal for Al...

The agreement will leverage SciNeuro’s proprietary blood-brain barrier shuttle t...